Shanghai UTGene Biotechnology

Shanghai UTGene Biotechnology, also known as Xingji Pharmaceutical (Shanghai) Co., Ltd., is a specialized biotechnology company focused on the development and supply of lipid materials and lipid nanoparticle (LNP) delivery systems. The company provides a comprehensive portfolio of ionizable lipids, including industry standards such as ALC-0315, SM-102, and MC3, as well as proprietary novel lipids designed to enhance the delivery of mRNA and other nucleic acid therapeutics. UTGene's technology platform is utilized across various research areas, including oncology, genetic disorders, and reproductive health, to improve the stability and tissue-specific targeting of RNA-based drugs. As a key supplier and service provider, the company supports the global life sciences community through high-quality reagent production and LNP formulation expertise. Its products are widely cited in pre-clinical research, particularly in the development of next-generation mRNA vaccines and therapies.